Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 203-275-7 | CAS number: 105-16-8
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
In an acute oral toxicity test the test substance performed according to OECD guideline 423 (BASF SE, 2015) a LD50 value of > 300 < 2000 mg/kg bw was determined. In an acute inhalation toxicity test with the test substance (aerosol) performed similarily to OECD guideline 403 (Haskell Laboratories, 1981) a LC50 of 1.8 mg/L was determined.
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 423 (Acute Oral toxicity - Acute Toxic Class Method)
- GLP compliance:
- yes (incl. QA statement)
- Test type:
- acute toxic class method
- Limit test:
- no
- Species:
- rat
- Strain:
- Wistar
- Sex:
- female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source:Charle River Wiga GmbH, Germany
- Age at study initiation: about 8-12 weeks
- Weight at study initiation:animals of comparable weigt (160-250 g) (+/-20%)
- Housing: single housing
- Diet (e.g. ad libitum): VRF1(P); SDS Special Diets Services, 67122 Altrip, Germany
- Water (e.g. ad libitum): Tap water ad libitum
- Acclimation period: at least 5 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 +/- 3°C
- Humidity (%): 30 -70
- Photoperiod (hrs dark / hrs light): 12/12 h - Route of administration:
- oral: gavage
- Vehicle:
- corn oil
- Details on oral exposure:
- 2000 mg/kg: concentration 40g/100ml (5 ml/kg administration volume) 20% solution in corn oil
- Doses:
- 300, 2000 mg/kg bw
- No. of animals per sex per dose:
- 3
- Control animals:
- no
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- > 300 - < 2 000 mL/kg bw
- Mortality:
- 2000 mg/kg: 3/2
300 mg/kg: 3/0 - Clinical signs:
- other: In one of the two animals which died in the single 2000 mg/kg bw test group impaired general state was noted at hour 0 which increased to poor general state at hour 1, while the other animal showed poor general state from hour 0 until hour 1. Piloerection
- Gross pathology:
- In the two animals that died in the 2000 mg/kg bw test group the following macroscopic pathological findings were observed: swollen small intestine, spotted discolored liver, red discoloration of the glandular stomach, congestion of the kidneys and red discoloration of the whole intestine including the appendix.
There were no macroscopic pathological findings in the animals sacrificed at the end of the observation period (2000 mg/kg bw: 1 female; 300 mg/kg: 6 females)
Reference
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed
- Dose descriptor:
- LD50
- Quality of whole database:
- GLP guideline study
Acute toxicity: via inhalation route
Link to relevant study records
- Endpoint:
- acute toxicity: inhalation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1981-9-30 - 1981-10-22
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: Guideline compliant study.
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 403 (Acute Inhalation Toxicity)
- Deviations:
- no
- GLP compliance:
- no
- Test type:
- standard acute method
- Limit test:
- no
- Species:
- rat
- Strain:
- Crj: CD(SD)
- Sex:
- male
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Age at study initiation: 7-8 weeks old
- Weight at study initiation: 230-270 g
- Fasting period before study:
- Housing: housed in pairs in stainless steal wire mesh cages
- Diet: Purino Rodent Chow #5002, ad libitum
- Water: ad libitum
- Acclimation period: 1 week - Route of administration:
- inhalation: aerosol
- Type of inhalation exposure:
- whole body
- Vehicle:
- air
- Details on inhalation exposure:
- GENERATION OF TEST ATMOSPHERE / CHAMBER DESCRIPTION
- Exposure apparatus:
- Exposure chamber volume:
- Method of holding animals in test chamber:
- Source and rate of air:
- Method of conditioning air:
- System of generating particulates/aerosols:
TEST ATMOSPHERE
- Brief description of analytical method used:
- Samples taken from breathing zone: yes - Analytical verification of test atmosphere concentrations:
- yes
- Duration of exposure:
- 4 h
- Concentrations:
- 0.4, 0.7, 1.1, 1.4, 1.8 mg/L
- No. of animals per sex per dose:
- 10 male animals per dose
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Sex:
- male
- Dose descriptor:
- LC50
- Effect level:
- 1.8 mg/L air
- Based on:
- test mat.
- Exp. duration:
- 4 h
- Mortality:
- At concentrations groups 0.4 - 1.8 no mortality occurred. At the highest dose group, 1.8 mg/L, 7 out of 10 animals died.
- Clinical signs:
- other: During exposure: All rats exhibited a clear nasal and oral discharge. Rats exposed exposed to 0.7 mg/L or greater exhibited hyperplasia of the extremities. Rats exposed to 1.1. mg/L or greater exhibited labored breathing, sporadic tremors, and convulsions
- Body weight:
- Rats exposed to 0.4 mg/L exhibited slight weight loss but showed no adverse clinical signs. Rats exposed to higher concentrations exhibited slight to severe weight loss lasting 1 to 4 days post exposure, followed by the resumption of a normal rate of weight gain.
- Gross pathology:
- No data
Reference
An approximate lethal concentration of 1.8 mg/L was determined for the test substance.
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed
- Dose descriptor:
- LC50
- Value:
- 1 800 mg/m³ air
- Quality of whole database:
- Scientifically reliable study.
Acute toxicity: via dermal route
Link to relevant study records
- Endpoint:
- acute toxicity: dermal
- Data waiving:
- other justification
- Justification for data waiving:
- other:
Reference
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
Acute toxicity oral
In an acute oral toxicity study performed according to the Acute Toxic Class method, doses of 2000 and 300 mg/kg bw of the test item Diethylaminoethyl Methacrylate (preparations in corn oil (20% of the test substance) were administered by gavage to three test groups of three fasted Wistar rats each (2000 mg/kg bw in 3 females, 300 mg/kg bw in 6 females). At 2000 mg/kg bw 2 of 3 animals died, at 300 mg/kg bw all animals survived. The acute oral LD50 was calculated to be LD50, oral, rat > 300 < 2000 mg/kg bw (BASF SE, 2015).
Supporting study
A single dose oral toxicity test with a read-across (RA) substance was performed according to OECD guideline 401. The RA test substance in corn oil was administered (gavage) in concentrations of 500, 100 and 2000 mg/kg bw to 5 males and 5 females rats per dose group. No mortality occurred in any of the treated groups. At necropsy, raised patches in the forestomach were observed in males of the 2000 mg/kg group. In the histopathological examination papiflomatous hyperplasia in the forestomnach was apparent. A LD50 value of > 2000 mg/kg bw was determined.
Acute toxicity inhalation
Groups of 10 male rats were exposed (whole body) to aerosol of the test substance for 4 hours in concentrations of 0.4, 0.7, 1.1, 1.4, 1.8 mg/L.
At concentrations groups 0.4 - 1.8 no mortality occurred. At the highest dose group, 1.8 mg/L, 7 out of 10 animals died.
During exposure: All rats exhibited a clear nasal and oral discharge. Rats exposed exposed to 0.7 mg/L or greater exhibited hyperplasia of the extremities. Rats exposed to 1.1. mg/L or greater exhibited labored breathing, sporadic tremors, and convulsions.
Post exposure: Rats exposed to 0.4 mg/L exhibited slight weight loss but showed no adverse clinical signs. Rats exposed to higher concentrations exhibited slight to severe weight loss lasting 1 to 4 days post exposure, followed by the resumption of a normal rate of weight gain. Rats exposed to 0.7 mg/L exhibited a clear nasal and oral discharge. At higher concentrations, rats exhibited red nasal discharge, labored breathing, lung noise, and cloudy eyes lasting 4 – 14 days post exposure. Severity and persistence of symptoms were proportional to exposure concentration.
Under the study conditions, an approximate lethal concentration of 1.8 mg/L was determined for the test substance.
Justification for selection of acute toxicity – oral endpoint
GLP guideline study
Justification for selection of acute toxicity – inhalation endpoint
The only available reliable study, performed similarly to an OECD guideline study.
Justification for classification or non-classification
The available studies were considered reliable and suitable for classification purposes under 67/548/EEC. As a result the substance is considered to be classified as Xn; R20/22 under Directive 67/548/EEC, as amended for the 31st time in Directive 2009/2/EG.
Classification, Labelling, and Packaging Regulation (EC) No 1272/2008
The available experimental test data are reliable and suitable for classification purposes under Regulation 1272/2008. As a result the substance is considered to be classified as acute Tox. 4; H302: Harmful if swallowed. and Acute Tox. 4; H332: Harmful if inhaled under Regulation (EC) No. 1272/2008, as amended for the sixth time in Regulation EC 605/2014.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.